Gary R. McLean

1.6k total citations · 1 hit paper
45 papers, 1.2k citations indexed

About

Gary R. McLean is a scholar working on Epidemiology, Molecular Biology and Infectious Diseases. According to data from OpenAlex, Gary R. McLean has authored 45 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Epidemiology, 12 papers in Molecular Biology and 11 papers in Infectious Diseases. Recurrent topics in Gary R. McLean's work include Respiratory viral infections research (9 papers), Cytomegalovirus and herpesvirus research (9 papers) and Monoclonal and Polyclonal Antibodies Research (8 papers). Gary R. McLean is often cited by papers focused on Respiratory viral infections research (9 papers), Cytomegalovirus and herpesvirus research (9 papers) and Monoclonal and Polyclonal Antibodies Research (8 papers). Gary R. McLean collaborates with scholars based in United Kingdom, United States and Canada. Gary R. McLean's co-authors include Yasmin Abo‐zeid, Nadia Μ. Hamdy, Nasser S. M. Ismail, Arturo Casadevall, Antonio Nakouzi, John W. Schrader, Sebastian L. Johnston, Nathan W. Bartlett, Marcela Torres and Natalia Elguezábal and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and The EMBO Journal.

In The Last Decade

Gary R. McLean

41 papers receiving 1.1k citations

Hit Papers

The Impact of Evolving SARS-CoV-2 Mutations and Variants ... 2022 2026 2023 2024 2022 40 80 120

Peers

Gary R. McLean
Richard A. Urbanowicz United Kingdom
Peter Rigsby United Kingdom
Ivana Knežević Switzerland
Natalie J. Thornburg United States
Georgina Cheng United States
Gary R. McLean
Citations per year, relative to Gary R. McLean Gary R. McLean (= 1×) peers Yi‐Chun Liu

Countries citing papers authored by Gary R. McLean

Since Specialization
Citations

This map shows the geographic impact of Gary R. McLean's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gary R. McLean with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gary R. McLean more than expected).

Fields of papers citing papers by Gary R. McLean

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gary R. McLean. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gary R. McLean. The network helps show where Gary R. McLean may publish in the future.

Co-authorship network of co-authors of Gary R. McLean

This figure shows the co-authorship network connecting the top 25 collaborators of Gary R. McLean. A scholar is included among the top collaborators of Gary R. McLean based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gary R. McLean. Gary R. McLean is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Huang, Jie, Gary R. McLean, & André Franke. (2025). Twenty years of genome-wide association studies: Health translation challenges and AI opportunities. European Journal of Human Genetics. 33(12). 1579–1584. 2 indexed citations
4.
Ismail, Nasser S. M., et al.. (2025). Antiviral Activity of Rhamnolipids Nano-Micelles Against Rhinoviruses—In Silico Docking, Molecular Dynamic Analysis and In-Vitro Studies. Current Issues in Molecular Biology. 47(5). 333–333.
5.
Nunn, Christine M., et al.. (2024). Antivirals for Broader Coverage against Human Coronaviruses. Viruses. 16(1). 156–156. 2 indexed citations
6.
Somogyvári, Ferenc, et al.. (2021). Decoding Covid-19 with the SARS-CoV-2 Genome. PubMed. 9(1). 1–12. 26 indexed citations
7.
Abo‐zeid, Yasmin, Nasser S. M. Ismail, Gary R. McLean, & Nadia Μ. Hamdy. (2020). A molecular docking study repurposes FDA approved iron oxide nanoparticles to treat and control COVID-19 infection. European Journal of Pharmaceutical Sciences. 153. 105465–105465. 188 indexed citations
8.
Abo‐zeid, Yasmin, et al.. (2020). An investigation of rhinovirus infection on cellular uptake of poly (glycerol-adipate) nanoparticles. International Journal of Pharmaceutics. 589. 119826–119826. 22 indexed citations
9.
Narean, Janakan Sam, Nicholas Glanville, Christine M. Nunn, et al.. (2019). Epitope mapping of antibodies induced with a conserved rhinovirus protein generating protective anti-rhinovirus immunity. Vaccine. 37(21). 2805–2813. 5 indexed citations
10.
Sapparapu, Gopal, Stephanie Planque, Yukie Mitsuda, et al.. (2012). Constant Domain-regulated Antibody Catalysis. Journal of Biological Chemistry. 287(43). 36096–36104. 13 indexed citations
11.
McLean, Gary R., Ross P. Walton, Tatiana Kebadze, et al.. (2012). Rhinovirus infections and immunisation induce cross-serotype reactive antibodies to VP1. Antiviral Research. 95(3). 193–201. 32 indexed citations
12.
Bartlett, Nathan W., Gary R. McLean, Yoon‐Seok Chang, & Sebastian L. Johnston. (2009). Genetics and epidemiology: asthma and infection. Current Opinion in Allergy and Clinical Immunology. 9(5). 395–400. 35 indexed citations
13.
Thomson, Christy A., S. Bryson, Gary R. McLean, et al.. (2008). Germline V‐genes sculpt the binding site of a family of antibodies neutralizing human cytomegalovirus. The EMBO Journal. 27(19). 2592–2602. 56 indexed citations
14.
McLean, Gary R., Cheong‐Weon Cho, & Jürgen Schrader. (2006). Autoreactivity of primary human immunoglobulins ancestral to hypermutated human antibodies that neutralize HCMV. Molecular Immunology. 43(12). 2012–2022. 5 indexed citations
15.
McLean, Gary R., Ole Olsen, Ian N. Watt, et al.. (2005). Recognition of Human Cytomegalovirus by Human Primary Immunoglobulins Identifies an Innate Foundation to an Adaptive Immune Response. The Journal of Immunology. 174(8). 4768–4778. 36 indexed citations
16.
McLean, Gary R., Marcela Torres, Michela Noseda, et al.. (2005). A point mutation in the Ch3 domain of human IgG3 inhibits antibody secretion without affecting antigen specificity. Molecular Immunology. 42(9). 1111–1119. 4 indexed citations
18.
McLean, Gary R., Antonio Nakouzi, Arturo Casadevall, & Nancy Green. (2000). Human and murine immunoglobulin expression vector cassettes. Molecular Immunology. 37(14). 837–845. 48 indexed citations
19.
McLean, Gary R., Michael J. Williams, C S Woodhouse, & Hermann J. Ziltener. (1998). Transcobalamin II andin vitroProliferation of Leukemic Cells. Leukemia & lymphoma. 30(1-2). 101–109. 7 indexed citations
20.
McLean, Gary R., Frazer J. Rixon, Nina Langeland, Lars Haarr, & H. S. Marsden. (1990). Identification and Characterization of the Virion Protein Products of Herpes Simplex Virus Type 1 Gene UL47. Journal of General Virology. 71(12). 2953–2960. 61 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026